Ir al contenido principal
← Toda la financiación verificada
Nivel AUS

Translational Neural Devices (R61/R33 - Clinical Trial Optional)

National Institutes of Health

Inicia sesión y completa tu Funding Passport para ver si calificas — un veredicto transparente basado en reglas, no una caja negra.

Iniciar sesión

Sobre esta oportunidad

The purpose of this Notice of Funding Opportunity (NOFO) is to encourage investigators to pursue translational activities and small clinical studies to advance the development of therapeutic, and diagnostic devices for disorders that affect the nervous or neuromuscular systems. Activities supported in this program include implementation of clinical prototype devices, non-clinical safety and efficacy testing, design verification and validation activities, obtaining an Investigational Device Exemption (IDE) for a Significant Risk (SR) study or Institutional Review Board (IRB) approval for a Non-Significant Risk (NSR) study, as well as a subsequent small clinical study. The clinical study is expected to provide information about the device function or final design that cannot be practically obtained through additional non-clinical assessments (e.g., bench top or animal studies) due to the novelty of the device or its intended use. This NOFO is a milestone-driven cooperative agreement program and will involve participation of NIH program staff in negotiating the final project plan before award and monitoring of research progress.

Documentos requeridos

La fuente oficial no indica documentos específicos aquí — confirme los requisitos antes de postular.

Fuente y trazabilidad de verificación

Primera obtención
20 de noviembre de 2026
Última verificación
20 de noviembre de 2026
Huella del contenido
1a01bbbe3505a1ad…